| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001095711A3 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 09/26/2002 | WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001071350A3 Methods of registering trans-membrane electric potentials |
| 09/26/2002 | WO2001047953A3 Antibodies against plasma cells |
| 09/26/2002 | WO2001032156A3 Methods for treating fibroproliferative diseases |
| 09/26/2002 | WO2001019845A9 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 09/26/2002 | WO2001018550A9 Determination of adrenomedullin-binding proteins |
| 09/26/2002 | WO2001011054A9 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 09/26/2002 | WO2001009204A9 Controlled-architecture polymers and use thereof as separation media |
| 09/26/2002 | WO2000070322A9 A-FORM OF CYTOPLASMIC DOMAIN OF nARIA (CRD-NEUREGULIN) AND USES THEREOF |
| 09/26/2002 | US20020138862 Mice show an increased insulin sensitivity, and resistance to weight gain compared to wild-type mice on same diet; screening for enzyme inhibitors; antiobesity, antidiabetic agents |
| 09/26/2002 | US20020138856 Rat selectively bred to be more depressed, as defined by a forced swim test immobility score; screening for antidepressants, genes responsible for depression |
| 09/26/2002 | US20020138222 Methods for the calibration of analyte assays |
| 09/26/2002 | US20020138220 Computerized laboratory information management system |
| 09/26/2002 | US20020138210 Microbial identification databases |
| 09/26/2002 | US20020138205 Expert system for analysis of DNA sequencing electropherograms |
| 09/26/2002 | US20020138204 Computer based modelling system |
| 09/26/2002 | US20020138203 Method and system for designing proteins and protein backbone configurations |
| 09/26/2002 | US20020137920 Magnetic pigment |
| 09/26/2002 | US20020137915 Conformational and topological protein regulation |
| 09/26/2002 | US20020137908 Novel guanosine triphosphate (GTP) binding protein-coupled receptor protein, BG3 |
| 09/26/2002 | US20020137888 Target module is prepared by binding selectively a target protein, modified to allow its detection, to a surrogate ligand that is linked to an individually detectable bead |
| 09/26/2002 | US20020137801 Administering gossypol; kits to treat patients |
| 09/26/2002 | US20020137797 Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate |
| 09/26/2002 | US20020137719 Particulate compositions for chemical synthesis |
| 09/26/2002 | US20020137700 Nucleic acids; genetic engineering |
| 09/26/2002 | US20020137695 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels |
| 09/26/2002 | US20020137682 Coupling spin probes such as 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid for immunoassay |
| 09/26/2002 | US20020137663 The anti-neoplastic agent ET-743 inhibits trans activation by SXR |
| 09/26/2002 | US20020137662 Compositions and methods for negative regulation of TGF-beta pathways |
| 09/26/2002 | US20020137343 Method for detecting metal contamination on a silicon chip by implanting arsenic |
| 09/26/2002 | US20020137234 Includes a cell with a working electrode and a sonicating device structurally coupled to the cell for sonicatin the contents of the cell; useful for diagnostic tests |
| 09/26/2002 | US20020137233 A bolaamphiphilic conjugated bisfunctional polydiacetylene, comprising a diacetylene unit at the center of a hydrophobic core, an anionic head group on one hydrophilic end and an oxy acid on the other hydrophilic end |
| 09/26/2002 | US20020137232 An analyte reacts with a particle-labeled anti- analyte, such as an antibody, to cause the particle(colloidal silver or gold particles)agglutination; quantitative analysis |
| 09/26/2002 | US20020137231 Device for the collection, testing and shipment of body fluid samples |
| 09/26/2002 | US20020137230 Biosensor is employed for a one-step immuno-chromatography |
| 09/26/2002 | US20020137226 Marking the biopolymers to be fractionated with magnetic beads of different sizes or materials causes different migration speeds and thus causes different postions of the biolpolymers after migration |
| 09/26/2002 | US20020137224 Method for determination of 5-hydroxycreatinine |
| 09/26/2002 | US20020137223 Reference standards for determining the purity or stability of amlodipine maleate and processes therefor |
| 09/26/2002 | US20020137222 Materials for enhancing staining of biopolymers in matrices |
| 09/26/2002 | US20020137220 Monitoring methods |
| 09/26/2002 | US20020137218 Microanalytic and microsynthetic analyses and procedures |
| 09/26/2002 | US20020137216 Determination of effect of ingredients and levels thereof on characteristics of dough and batter-based products |
| 09/26/2002 | US20020137209 Nongenotropic effect occurs due to a ligand-induced activation of the ligand binding domain and genotropic effect occurs due to a ligand-induced activation of the DNA-binding domain of a steroid receptor |
| 09/26/2002 | US20020137205 Lipid uptake assays |
| 09/26/2002 | US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it |
| 09/26/2002 | US20020137201 Detection of transmembrane potentials by optical methods |
| 09/26/2002 | US20020137200 High-accuracy blood component analysis can be performed easily and quickly with less cost |
| 09/26/2002 | US20020137195 Contacting unoxidized carbon, silicon, or germanium substrate with a bromine- or iodine- containing reactant to form an unoxidized, bromine- or iodine-terminated carbon, silicon, or germanium substrate, reacting with alkene |
| 09/26/2002 | US20020137193 Electrochemical affinity assay |
| 09/26/2002 | US20020137189 Cardiac hypertrophy factor and uses therefor |
| 09/26/2002 | US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof |
| 09/26/2002 | US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death |
| 09/26/2002 | US20020137180 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/26/2002 | US20020137171 Nucleic acid encoding a polypeptide having hydrolase activity |
| 09/26/2002 | US20020137170 Dual-specificity protein tyrosine phosphatases that dephosphorylate both phosphotyrosine and phosphothreonine/serine residues |
| 09/26/2002 | US20020137166 ASIP-related proteins |
| 09/26/2002 | US20020137161 Protein expression and structure solution using specific fusion vectors |
| 09/26/2002 | US20020137142 Tango-73 nucleic acids |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |
| 09/26/2002 | US20020137129 Polypeptides; genetic engineering; drug development |
| 09/26/2002 | US20020137127 Culture product; polypeptides |
| 09/26/2002 | US20020137122 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria |
| 09/26/2002 | US20020137121 Cell viability detection using electrical measurements |
| 09/26/2002 | US20020137119 Immunoassay; quantitative analysis |
| 09/26/2002 | US20020137117 Support strips; pH indicator |
| 09/26/2002 | US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same |
| 09/26/2002 | US20020137114 Central nervous system disorders |
| 09/26/2002 | US20020137113 Kinase receptor activation assay |
| 09/26/2002 | US20020137112 Monitoring using adduct of amyloid protein modified with malonaldehyde |
| 09/26/2002 | US20020137111 Chlamydia heat shock protein |
| 09/26/2002 | US20020137110 Detecting apoptosis |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020137108 CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's disease |
| 09/26/2002 | US20020137107 Method for identifying agents which modulate chemokine "MEC"-induced functions of CCR3 and/or CCR10 |
| 09/26/2002 | US20020137106 Signal transduction |
| 09/26/2002 | US20020137105 Radioimmunoassay; diagnosis of liver cancer |
| 09/26/2002 | US20020137104 High throughput determination of antigen expression |
| 09/26/2002 | US20020137103 Short turnaround time insulin assay and protocol therefor |
| 09/26/2002 | US20020137100 Method for determining the fertility of mammals, especially of humans |
| 09/26/2002 | US20020137099 Repsiratory system disorders |
| 09/26/2002 | US20020137098 Methods for detecting retinopathy of prematurity |
| 09/26/2002 | US20020137097 Immunoassay; quantitative analysis |
| 09/26/2002 | US20020137096 Solid phase synthesis; photolithography |
| 09/26/2002 | US20020137095 Reelin protein CR-50 epitope region |
| 09/26/2002 | US20020137092 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto- immune antibodies |
| 09/26/2002 | US20020137091 Labeling with fluorescent dyes; forming libraries |
| 09/26/2002 | US20020137090 Binding optical fibers |
| 09/26/2002 | US20020137088 Detecting Dna sequence in blood sampling; calibrating hybridization |
| 09/26/2002 | US20020137087 Complexing; quantitative analysis |
| 09/26/2002 | US20020137086 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
| 09/26/2002 | US20020137085 Multiplexed generation of chemical or physical events |
| 09/26/2002 | US20020137084 Method for detecting chemical interactions between naturally occurring biological analyte molecules |
| 09/26/2002 | US20020137082 Calibration using chaperone protein |
| 09/26/2002 | US20020137068 Reagents for labeling biomolecules having aldehyde or ketone Moieties |
| 09/26/2002 | US20020137064 Id-1 and Id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |